SCHEMBL2253083

SCHEMBL2253083

O=C(O)c1ccc(-c2ccc(F)cc2)cc1C(O)C(O)c1ccc2cccc(O)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN2D O15399 1/20 0.42
▸ GRIN2A Q12879 1/20 0.42
▸ GRIN2B Q13224 1/20 0.42
▸ GRIN2C Q14957 1/20 0.42
▸ BCL2L1 Q07817 1/20 0.39
▸ BAD Q92934 1/20 0.39
▸ ACMSD Q8TDX5 5/20 0.38
▸ HNF4A P41235 2/20 0.38
▸ MCL1 Q07820 2/20 0.38
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ DHODH Q02127 2/20 0.36
▸ LDHA P00338 1/20 0.35
▸ DHFR P00374 1/20 0.35
▸ HSD17B1 P14061 2/20 0.35
▸ HSD17B2 P37059 2/20 0.35
▸ XDH P47989 2/20 0.35
▸ SLC22A12 Q96S37 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2254743 0.73 GRIN2D (0.42) GRIN2DGRIN2AGRIN2BGRIN2CBCL2L1
SCHEMBL2255104 0.73 BCL2L1 (0.67) GRIN2DGRIN2AGRIN2BGRIN2CBCL2L1
SCHEMBL2257615 0.73 SOX18 (0.46) GRIN2DGRIN2AGRIN2BGRIN2CBCL2L1
SCHEMBL2255199 0.73 AKR1C3 (0.47) GRIN2DGRIN2AGRIN2BGRIN2CMCL1
SCHEMBL2255098 0.73 BCL2L1 (0.67) GRIN2DGRIN2AGRIN2BGRIN2CBCL2L1
SCHEMBL2257660 0.72 ACLY (0.49) GRIN2DGRIN2AGRIN2BGRIN2CMEN1
SCHEMBL2253800 0.72 ACLY (0.50) GRIN2DGRIN2AGRIN2BGRIN2CBCL2L1
SCHEMBL2254380 0.72 DCLRE1B (0.43) GRIN2DGRIN2AGRIN2BGRIN2CBCL2L1
SCHEMBL2256052 0.70 BCL2L1 (0.51) GRIN2DGRIN2AGRIN2BGRIN2CBCL2L1
SCHEMBL2255077 0.70 ACLY (0.52) MEN1KMT2APPARASTING1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904047-B1 APOPTOSIS PROMOTERS ABBOTT LAB (US) 2013-01-02 — — EP disclosed
US-7989656-B2 Biaryl carboxylic acid apoptosis promoters ABBOTT LABORATORIES (US) 2011-08-02 — — US disclosed
US-20100234456-A1 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2010-09-16 — — US disclosed
US-7750004-B2 Apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-06 — — US disclosed
US-20070135392-A1 Apoptosis promoters ABBVIE INC. 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234456-A1 APOPTOSIS PROMOTERS MCL1, BAX, BCL2 GRIN2D 4683/4885GRIN2A 3979/4885GRIN2B 3985/4885
US-20070135392-A1 Apoptosis promoters MCL1, BAX, BCL2 GRIN2D 4683/4885GRIN2A 3979/4885GRIN2B 3985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback